Presentation is loading. Please wait.

Presentation is loading. Please wait.

Chapter 5 Lifespan and Cultural Modifications Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc. 1.

Similar presentations


Presentation on theme: "Chapter 5 Lifespan and Cultural Modifications Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc. 1."— Presentation transcript:

1 Chapter 5 Lifespan and Cultural Modifications Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc. 1

2 Chapter 5 Lesson 5.1 2 Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

3 Learning Objectives  Identify specific considerations in administering medications to pediatric, pregnant, breastfeeding, or elderly patients 3 Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

4 U.S. Food and Drug Administration (FDA)  Establishes standards that require drug companies to provide consumers with specific drug information  Information is printed on product package insert (PPI)  Information includes:  Description of therapeutic response  Side effects  Adverse effects  Possible drug interactions 4 Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

5 The Pediatric Patient  Variables have a profound impact on drug action and effect  Neonates (less than 1 month of age)  Small body mass  Low body fat content  High body water volume  Increased membrane permeability 5 Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

6 The Pediatric Patient (cont.)  Variables have a profound impact on drug absorption  No gastric acid present at birth  No intestinal bacteria or enzyme function present  Delayed gastrointestinal transit time  Immaturity of liver, kidney, and renal excretion systems 6 Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

7 Question 1 Drug effect in a neonate differs from that in an adult because of the newborn’s: 1. Larger head to body mass ratio. 2. High body fat content. 3. High body water volume. 4. Decreased membrane permeability. 7 Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

8 Absorption  Three principles in the pediatric patient  The physiologic status of the infant or child determines the blood flow at the site of intramuscular or subcutaneous drug administration.  Compared with older children and adults, premature infants have immature and unstable body processes.  A newborn’s skin, particularly that of premature infants, has a greater ability to absorb some chemicals because of its greater hydration. 8 Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

9 Distribution  Two factors  The chemical properties of the drug (do not vary)  The physiologic factors specific to the patient (do vary) 9 Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

10 Metabolism  The majority of drug metabolism, or biotransformation, takes place in the liver.  In general, drug metabolism in infants is much slower than in older children and adults.  Until 3 to 4 years of age, children have the ability to increase production of liver enzymes.  Neonates have a decreased ability to metabolize drugs. 10 Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

11 Excretion  Renal system may still be immature at birth  Decreased glomerular filtration  Decreased tubular secretion  Decreased tubular reabsorption  System still maturing over the first year of life  Drug clearance can be compromised 11 Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

12 Adverse Drug Reactions  Children are exposed to drugs directly and indirectly  Transplacentally during pregnancy or delivery  Direct administration  Through ingested breast milk 12 Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

13 The Geriatric Patient  Reacts differently to medications than younger adults do  Drugs absorbed, metabolized, and excreted more slowly and less completely  Variability in drug response and clearance related to aging organ systems and overall health or illness  Patients age differently; body responses vary 13 Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

14 Geriatric Patient Teaching  Drug nonadherence related to:  Drug cost  Difficulty obtaining drugs  Diminished cognitive abilities  Lack of desire to take on schedule  Depression  Feelings of being overwhelmed with physical needs  Physical disabilities requiring assistance to administer 14 Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

15 Question 2 Drugs metabolized by the __________ should be used with caution in elderly patients. 1. stomach 2. liver 3. pancreas 4. small intestine 15 Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

16 Chapter 5 Lesson 5.2 16 Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

17 Learning Objectives  Identify specific considerations in administering medications to pediatric, pregnant, breastfeeding, or elderly patients  Identify special considerations for providing care to individuals from different cultures  Describe specific nursing behaviors that assist in helping patients succeed with their medication plans 17 Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

18 Medications Used by Women  Females differ from males in hormonal makeup  Medication needs are often related to:  Genital tract infections  Menstruation  Infertility  Pregnancy  Menopause 18 Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

19 Medications and Pregnancy  1961, thalidomide  Teratogenic = likely to cause fetal or embryonic damage or malformations  Few “safe” medications during pregnancy  Weigh benefit of drug for mother against risk to fetus 19 Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

20 Medications, Pregnancy, and Breastfeeding  Some medications cross the immature blood- brain barrier of the fetus  Some medications cross the placenta to the fetus  Some medications pass into breast milk to the baby during nursing 20 Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

21 Childhood Immunizations  Essential for personal and national protection  Factors related to delay in receiving  Health care provider belief of need to delay related to symptoms of mild illness  Parental refusal from concern over adverse effects 21 Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

22 Medications Used Throughout the Lifespan  Antidiabetic agents  Antihypertensive agents  Cholesterol-lowering drugs  Smoking-cessation products  Weight-loss drugs  Antidepressant medications  Impotence drugs  Aspirin  Caffeine 22 Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

23 Question 3 What percent of cases of childhood asthma have been linked to the effects of passive smoking? 1. 30% 2. 40% 3. 50% 4. 60% 23 Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

24 Cultural Influences  Cultural assessment includes determining  Values  Religion  Dietary practices  Family lines of authority  Family life patterns  Beliefs and practices related to health and illness 24 Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

25 Nursing Assessment of Health Care Availability  Health disparity  Health literacy 25 Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.

26 Medication Nonadherence  Six major reasons for client nonadherence  Medications are for prevention  Increases with prolonged therapy  Treatment requires significant changes in behavior  Poor patient understanding  Complexity of treatment plan  Unpleasant side effects 26 Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc.


Download ppt "Chapter 5 Lifespan and Cultural Modifications Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc. 1."

Similar presentations


Ads by Google